Cargando…

Simultaneous Quantification of Nine Antimicrobials by LC-MS/MS for Therapeutic Drug Monitoring in Critically Ill Patients

BACKGROUND: Adequate antibiotic treatment is a prerequisite for the successful treatment of systemic infections. Based on accumulating scientific evidence, a fixed dosage regimen can lead to insufficient and ineffective antibiotic therapy. Thus, the aim of this study was to develop and validate a si...

Descripción completa

Detalles Bibliográficos
Autores principales: Neugebauer, Sophie, Wichmann, Christina, Bremer-Streck, Sibylle, Hagel, Stefan, Kiehntopf, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Therapeutic Drug Monitoring 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6358189/
https://www.ncbi.nlm.nih.gov/pubmed/30320624
http://dx.doi.org/10.1097/FTD.0000000000000570
_version_ 1783391966712561664
author Neugebauer, Sophie
Wichmann, Christina
Bremer-Streck, Sibylle
Hagel, Stefan
Kiehntopf, Michael
author_facet Neugebauer, Sophie
Wichmann, Christina
Bremer-Streck, Sibylle
Hagel, Stefan
Kiehntopf, Michael
author_sort Neugebauer, Sophie
collection PubMed
description BACKGROUND: Adequate antibiotic treatment is a prerequisite for the successful treatment of systemic infections. Based on accumulating scientific evidence, a fixed dosage regimen can lead to insufficient and ineffective antibiotic therapy. Thus, the aim of this study was to develop and validate a simplified, but sensitive method for the simultaneous quantification of antimicrobials by using liquid chromatography with tandem mass spectrometry (LC-MS/MS) for the development of personalized therapy regimens using therapeutic drug monitoring. METHODS: A method was developed for the simultaneous quantification of 9 antimicrobials (aciclovir, ampicillin, cefuroxime, ciprofloxacin, meropenem, metronidazole, piperacillin, rifampicin, and tazobactam) in lithium–heparin plasma. A simple sample preparation method and a chromatographic run time of 10 minutes enabled the quick processing of the samples. The method was validated according to the guidelines for bioanalytical method validation of the European Medicines Agency and addressed sensitivity, specificity, linearity, accuracy, precision, dilution integrity, carry-over, recovery, matrix effects, and stability. RESULTS: The chromatographic run time was 10 minutes and antimicrobials eluted at retention times ranging from 1.1 to 2.2 minutes. Calibration curve for all antimicrobials was linear over a range of 1–100 mg/L, and a 2-fold or 5-fold dilution of the samples was possible. The method accuracy ranged from 85.1% to 114.9% for all measured antimicrobials, and the within- and between-run precision values were <11.9% and <16.5% for the lower limit of quantification. No interferences and carry-over were observed. The samples were stable for at least 5 hours at room temperature or in the autosampler (10°C). CONCLUSIONS: The LC-MS/MS method developed in this study is appropriate and practical for the therapeutic drug monitoring of antimicrobials in the daily clinical laboratory practice because of its short analysis time, the need for a small amount of plasma, high specificity, and accuracy.
format Online
Article
Text
id pubmed-6358189
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Therapeutic Drug Monitoring
record_format MEDLINE/PubMed
spelling pubmed-63581892019-02-20 Simultaneous Quantification of Nine Antimicrobials by LC-MS/MS for Therapeutic Drug Monitoring in Critically Ill Patients Neugebauer, Sophie Wichmann, Christina Bremer-Streck, Sibylle Hagel, Stefan Kiehntopf, Michael Ther Drug Monit Original Article BACKGROUND: Adequate antibiotic treatment is a prerequisite for the successful treatment of systemic infections. Based on accumulating scientific evidence, a fixed dosage regimen can lead to insufficient and ineffective antibiotic therapy. Thus, the aim of this study was to develop and validate a simplified, but sensitive method for the simultaneous quantification of antimicrobials by using liquid chromatography with tandem mass spectrometry (LC-MS/MS) for the development of personalized therapy regimens using therapeutic drug monitoring. METHODS: A method was developed for the simultaneous quantification of 9 antimicrobials (aciclovir, ampicillin, cefuroxime, ciprofloxacin, meropenem, metronidazole, piperacillin, rifampicin, and tazobactam) in lithium–heparin plasma. A simple sample preparation method and a chromatographic run time of 10 minutes enabled the quick processing of the samples. The method was validated according to the guidelines for bioanalytical method validation of the European Medicines Agency and addressed sensitivity, specificity, linearity, accuracy, precision, dilution integrity, carry-over, recovery, matrix effects, and stability. RESULTS: The chromatographic run time was 10 minutes and antimicrobials eluted at retention times ranging from 1.1 to 2.2 minutes. Calibration curve for all antimicrobials was linear over a range of 1–100 mg/L, and a 2-fold or 5-fold dilution of the samples was possible. The method accuracy ranged from 85.1% to 114.9% for all measured antimicrobials, and the within- and between-run precision values were <11.9% and <16.5% for the lower limit of quantification. No interferences and carry-over were observed. The samples were stable for at least 5 hours at room temperature or in the autosampler (10°C). CONCLUSIONS: The LC-MS/MS method developed in this study is appropriate and practical for the therapeutic drug monitoring of antimicrobials in the daily clinical laboratory practice because of its short analysis time, the need for a small amount of plasma, high specificity, and accuracy. Therapeutic Drug Monitoring 2019-02 2018-10-12 /pmc/articles/PMC6358189/ /pubmed/30320624 http://dx.doi.org/10.1097/FTD.0000000000000570 Text en Copyright © 2018 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Original Article
Neugebauer, Sophie
Wichmann, Christina
Bremer-Streck, Sibylle
Hagel, Stefan
Kiehntopf, Michael
Simultaneous Quantification of Nine Antimicrobials by LC-MS/MS for Therapeutic Drug Monitoring in Critically Ill Patients
title Simultaneous Quantification of Nine Antimicrobials by LC-MS/MS for Therapeutic Drug Monitoring in Critically Ill Patients
title_full Simultaneous Quantification of Nine Antimicrobials by LC-MS/MS for Therapeutic Drug Monitoring in Critically Ill Patients
title_fullStr Simultaneous Quantification of Nine Antimicrobials by LC-MS/MS for Therapeutic Drug Monitoring in Critically Ill Patients
title_full_unstemmed Simultaneous Quantification of Nine Antimicrobials by LC-MS/MS for Therapeutic Drug Monitoring in Critically Ill Patients
title_short Simultaneous Quantification of Nine Antimicrobials by LC-MS/MS for Therapeutic Drug Monitoring in Critically Ill Patients
title_sort simultaneous quantification of nine antimicrobials by lc-ms/ms for therapeutic drug monitoring in critically ill patients
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6358189/
https://www.ncbi.nlm.nih.gov/pubmed/30320624
http://dx.doi.org/10.1097/FTD.0000000000000570
work_keys_str_mv AT neugebauersophie simultaneousquantificationofnineantimicrobialsbylcmsmsfortherapeuticdrugmonitoringincriticallyillpatients
AT wichmannchristina simultaneousquantificationofnineantimicrobialsbylcmsmsfortherapeuticdrugmonitoringincriticallyillpatients
AT bremerstrecksibylle simultaneousquantificationofnineantimicrobialsbylcmsmsfortherapeuticdrugmonitoringincriticallyillpatients
AT hagelstefan simultaneousquantificationofnineantimicrobialsbylcmsmsfortherapeuticdrugmonitoringincriticallyillpatients
AT kiehntopfmichael simultaneousquantificationofnineantimicrobialsbylcmsmsfortherapeuticdrugmonitoringincriticallyillpatients